Literature DB >> 16754376

Magnetic PECA nanoparticles as drug carriers for targeted delivery: synthesis and release characteristics.

J Yang1, H Lee, W Hyung, S-B Park, S Haam.   

Abstract

Magnetic poly(ethyl-2-cyanoacrylate) (PECA) nanoparticles containing anti-cancer drugs (Cisplatin and Gemcitabine) were prepared by inter-facial polymerization. The spherical nanoparticles (d = 250 +/- 15 nm) with smooth surfaces and moderately uniform size distributions were obtained. The amount of magnetite encapsulated inside the polymer matrix was increased up to 14.26% (w/w) by controlling the initial weight ratio of monomer/magnetite. It was found that the amount of Cisplatin encapsulated in the magnetic nanoparticle is much higher than that of Gemcitabine because Cisplatin (hydrophobic) is highly soluble in the oil phase and encapsulated easier inside nanoparticles compared to Gemcitabine (hydrophilic). The presence of magnetite and its super-paramagnetic characteristic were confirmed by FTIR spectra and VSM. In-vitro experiments of drug release and magnetic mobility under external magnetic field demonstrated that magnetic poly(ethyl-2-cyanoacrylate) (PECA) nanoparticles can be a highly versatile magnetic drug carrier with sustained release behaviour and sufficient magnetic susceptibility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16754376     DOI: 10.1080/02652040500435444

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  8 in total

1.  Synthesis and characterization of collagen/hydroxyapatite: magnetite composite material for bone cancer treatment.

Authors:  Ecaterina Andronescu; Maria Ficai; Georgeta Voicu; Denisa Ficai; Maria Maganu; Anton Ficai
Journal:  J Mater Sci Mater Med       Date:  2010-04-07       Impact factor: 3.896

Review 2.  Application of in situ polymerization for design and development of oral drug delivery systems.

Authors:  Ndidi Ngwuluka
Journal:  AAPS PharmSciTech       Date:  2010-11-11       Impact factor: 3.246

Review 3.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

4.  Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin.

Authors:  Jyoti Choubey; A K Bajpai
Journal:  J Mater Sci Mater Med       Date:  2010-02-05       Impact factor: 3.896

5.  Core-shell nanoparticulate formulation of gemcitabine: lyophilization, stability studies, and in vivo evaluation.

Authors:  Deepak Chitkara; Anupama Mittal; Ram I Mahato; Neeraj Kumar
Journal:  Drug Deliv Transl Res       Date:  2014-12       Impact factor: 4.617

6.  Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment.

Authors:  William J Trickler; Jatin Khurana; Ankita A Nagvekar; Alekha K Dash
Journal:  AAPS PharmSciTech       Date:  2010-03-18       Impact factor: 3.246

7.  Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro.

Authors:  Jin-ming Li; Wei Chen; Hao Wang; Chen Jin; Xian-jun Yu; Wei-yue Lu; Long Cui; De-liang Fu; Quan-xing Ni; Hui-min Hou
Journal:  Acta Pharmacol Sin       Date:  2009-09       Impact factor: 6.150

Review 8.  The Potential of Magnetic Nanoparticles for Diagnosis and Treatment of Cancer Based on Body Magnetic Field and Organ-on-the-Chip.

Authors:  Ali Alirezaie Alavijeh; Mohammad Barati; Meisam Barati; Hussein Abbasi Dehkordi
Journal:  Adv Pharm Bull       Date:  2019-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.